Title: Selective orexin receptor antagonists.
Journal: Bioorganic & medicinal chemistry letters 20130901
Title: Neuroendocrine regulatory peptide-1 and neuroendocrine regulatory peptide-2 influence differentially feeding and penile erection in male rats: sites of action in the brain.
Journal: Regulatory peptides 20120820
Title: The osmotically and histamine-induced enhancement of the plasma vasopressin level is diminished by intracerebroventricularly administered orexin in rats.
Journal: Pflugers Archiv : European journal of physiology 20120401
Title: Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone.
Journal: PloS one 20120101
Title: Ligand-induced internalization of the orexin OX(1) and cannabinoid CB(1) receptors assessed via N-terminal SNAP and CLIP-tagging.
Journal: British journal of pharmacology 20110301
Title: Activation of orexin/hypocretin type 1 receptors stimulates cAMP synthesis in primary cultures of rat astrocytes.
Journal: Pharmacological reports : PR 20110101
Title: [Cardiovascular effect of intracerebroventricular injection of orexin-1 receptor antagonist in rats].
Journal: Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20100801
Title: Modulation of respiratory activity by hypocretin-1 (orexin A) in situ and in vitro.
Journal: Advances in experimental medicine and biology 20100101
Title: Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat.
Journal: The Journal of pharmacology and experimental therapeutics 20090701
Title: Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network.
Journal: Biological psychiatry 20090515
Title: Langmead CJ, et al. Characterisation of the binding of H-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor. Br J Pharmacol. 2004;141(2):340-346.
Title: Kis GK, et al. The osmotically and histamine-induced enhancement of the plasma vasopressin level is diminished by intracerebroventricularly administered orexin in rats. Pflugers Arch. 2012;463(4):531-536.
